3 results
Aimovig (Erenumab)
Mechanism: Calcitonin Gene-related Peptide Receptor Antagonist 
Indication: Preventive Treatment of Migraines:
Dosing: 70 mg SQ monthly,
Aimovig (Erenumab ... Receptor Antagonist Indication ... reported this drug ... Erenumab #Migraine #Neurology ... #Pharmacology #
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Neurological symptoms ... : Acute onset 2 ... Electrolyte abnormality, Medication ... /Drug toxicity, ... diagnosis #management #neurology
Evaluation of Recurrent Falls

Core Concept:
Maintaining an upright posture requires the integrated function of multiple systems.
Disruption in
presyncope, exertional symptoms ... positive Romberg sign ... Contributing Factors • Medications ... slippery surfaces • Psychiatric ... Evaluation #Geriatrics #Neurology